Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
Journal of Neuro-Oncology|January 1, 1984
Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group studyH J Eyre, J D Ohlsen, J Frank, et al.Journal of Biological Response Modifiers|April 1, 1988
Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibodyD R Shaw, G Harrison, L K Sun, et al.Gene Therapy|January 1, 1995
A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activityR M Conry, A F LoBuglio, F Loechel, et al.Cancer Gene Therapy|April 15, 2000
SEREX analysis for tumor antigen identification in a mouse model of adenocarcinomaT A Hampton, R M Conry, M B Khazaeli, et al.The Journal of Gene Medicine|May 16, 2000
Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccineS A White, A F LoBuglio, R B Arani, et al.Clinical Nuclear Medicine|February 1, 1991
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomasM N Saleh, R H Wheeler, J Y Lee, et al.American Journal of Clinical Oncology|February 1, 1989
A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapyR H Clark, N V Dimitrov, J A Axelson, et al.Seminars in Oncology|February 28, 2001
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopeniaM N Saleh, J Gutheil, M Moore, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Expression of human endogenous retrovirus k envelope transcripts in human breast cancerF Wang-Johanning, A R Frost, G L Johanning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancerR F Meredith, M B Khazaeli, D J Macey, et al.Pageof 13